CRVS — Corvus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $895.89m
- $680.66m
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental
Corvus rises as it invests in China partner to advance skin, asthma drug trials
Corvus Pharmaceuticals Q1 swings to loss as R&D costs rise
US STOCKS ON THE MOVE-Kyivstar Group, Applied Materials, Tevogen Bio
U.S. STOCKS ON THE MOVE-Carvana, Circle, Voyager Acquisition Corp
U.S. STOCKS ON THE MOVE-PayPay Corp, Ulta Beauty, InMode
Biotech Corvus expands stock sale agreement with Jefferies, shares down
Corvus Pharmaceuticals Q4 net loss widens on higher R&D costs
Brief: Corvus Pharmaceuticals Q4 EPS USD -0.15
U.S. RESEARCH ROUNDUP- Applied Materials, Procter & Gamble, RLI
U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel
U.S. STOCKS ON THE MOVE-Autodesk, Teledyne, Alphabet
U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital
U.S. STOCKS ON THE MOVE-Micron, Rambus, GE Aerospace
Corvus Pharma extends gains after boosted $175 mln equity raise
Brief: Corvus Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock